Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > 9 BM0 F... idiot

<< Previous

Bullboard Posts

Next >>

Post by jomagon Mar 01, 2019 10:33am

79 Views

Post# 29428501

9 BM0 F... idiot

V:ICO Depth by Order @10:31:19

Bid			Ask
Broker	Size	Price	Price	Size	Broker
79 CIBC	26,000	0.08	0.085	65,000	7 TD Sec
19 Desjardins	50,000	0.08	0.09	23,000	85 Scotia
1 Anonymous	125,000	0.08	0.09	5,000	79 CIBC
79 CIBC	25,000	0.08	0.09	5,000	2 RBC
80 National Bank	10,000	0.08	0.09	10,000	80 National Bank
28 BBS	25,000	0.08	0.09	673,571	9 BMO Nesbitt
2 RBC	10,000	0.08	0.09	4,666	79 CIBC
2 RBC	5,000	0.08	0.095	29,000	79 CIBC
7 TD Sec	25,000	0.08	0.095	23,500	88 Credential
28 BBS	50,000	0.08	0.095	10,000	80 National Bank